Literature DB >> 10973797

Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

T Nakashima1, Y Kobayashi, S Yamasaki, A Kawakami, K Eguchi, H Sasaki, H Sakai.   

Abstract

A variety of humoral factors modulate the osteoclastogenesis. Receptor activator of NF-kappaB ligand (RANKL) expressed on osteoblast/stromal lineage cells plays a pivotal role to transduce an essential differentiation signal to osteoclast lineage cells through binding to its receptor, RANK, expressed on the latter cell population; however, the difficulty to detect RANKL protein expression hampers us in investigating the regulation of RANKL expression by humoral factors. To determine protein expression of RANKL, we have established a new method, named as a ligand-receptor precipitation (LRP) Western blot analysis, which can specifically concentrate the target protein by the use of specific binding characteristic between RANKL and RANK/osteoprotegrin (OPG). RANKL protein expression in the postnuclear supernatant was not detected by common Western blotting, but LRP Western blot analysis clearly showed that RANKL is produced as a membrane-bound protein on murine osteoblasts/stromal cells, and cleaved into a soluble form by metalloprotease. Cytokines stimulating the osteoclastogenesis, such as IL-1beta, IL-6, IL-11, IL-17, and TNF-alpha, increased the expression of RANKL with decrease of OPG expression in osteoblasts/stromal cells. In contrast, cytokines inhibiting the osteoclastogenesis, such as IL-13, INF-gamma, and TGF-beta1 suppressed the expression of RANKL and/or augmented OPG expression. Functional difference between membrane-bound and soluble RANKL was demonstrated, which showed that membrane-bound RANKL works more efficiently than soluble RANKL in the osteoclastogenesis developed from murine bone marrow cell culture. The present study indicates the usefulness of LRP Western blot analysis, which shows that the modulation of osteoclastogenesis by humoral factors is achieved, in part, by regulation of the expression of RANKL and OPG in osteoblast/stromal lineage cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10973797     DOI: 10.1006/bbrc.2000.3379

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  134 in total

Review 1.  Novel host response therapeutic approaches to treat periodontal diseases.

Authors:  Keith L Kirkwood; Joni A Cirelli; Jill E Rogers; William V Giannobile
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

2.  Relation of interleukin-6 in rheumatoid arthritis patients to systemic bone loss and structural bone damage.

Authors:  Mona Helmy Abdel Meguid; Yousry Hasan Hamad; Rania Shafek Swilam; Mohamed Samy Barakat
Journal:  Rheumatol Int       Date:  2012-04-25       Impact factor: 2.631

Review 3.  RANKL inhibition: a promising novel strategy for breast cancer treatment.

Authors:  Eva González-Suárez
Journal:  Clin Transl Oncol       Date:  2011-04       Impact factor: 3.405

Review 4.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

5.  Translocation of Endogenous Danger Signal HMGB1 From Nucleus to Membrane Microvesicles in Macrophages.

Authors:  Yan Chen; Guangping Li; Yanxia Liu; Victoria P Werth; Kevin Jon Williams; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2016-03-09       Impact factor: 6.384

Review 6.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

7.  Effects of titanium particle size on osteoblast functions in vitro and in vivo.

Authors:  Moon G Choi; Hae S Koh; Daniel Kluess; Daniel O'Connor; Anshu Mathur; George A Truskey; Janet Rubin; David X F Zhou; K-L Paul Sung
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

8.  Hydrogen sulfide epigenetically mitigates bone loss through OPG/RANKL regulation during hyperhomocysteinemia in mice.

Authors:  Jyotirmaya Behera; Akash K George; Michael J Voor; Suresh C Tyagi; Neetu Tyagi
Journal:  Bone       Date:  2018-06-13       Impact factor: 4.398

9.  Tumor necrosis factor-alpha regulation of CD4+CD25+ T cell levels in NOD mice.

Authors:  Ava J Wu; Hong Hua; Sibyl H Munson; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-09       Impact factor: 11.205

10.  Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

Authors:  L Danks; A Sabokbar; R Gundle; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.